Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BrainTale has developed a CE-marked software medical device that provides non-invasive, quantitative biomarkers of white matter integrity using diffusion MRI. The technology supports early diagnosis, prognosis prediction, monitoring of neurological conditions progression and treatment efficacy evaluation. Preliminary results have demonstrated utility in demyelinating diseases and Parkinson's disease; further clinical validation studies are ongoing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BrainTale.